Overview of glycemic control among admitted patients with diabetes in Tripoli University Hospital
Article Sidebar
Main Article Content
Abstract
Aim: To examine the relationship between the levels of HbA1c and hospital admission rates.
Methods: We recorded HbA1c levels of all diabetic patients in Tripoli University Hospital over one year.
Results: The mean HbA1c was 8.03%, with no difference between males and females. Over half of patients (56.5%) were admitted through their diabetes was well-controlled. Over half of the patients with type 1 diabetes (57/102, 55.9%) had a high HbA1c at admission compared to 42.1% of patients with type 2, who were mainly admitted with HbA1c level within the acceptable range set for this study. The HbA1c level was positively and significantly correlated with the length of hospital stay (R = 0.93, p = 0.000), and was significantly associated with hyperglycemia, diabetic ketoacidosis, coronary artery disease, limb ischemia, cataract, osteomyelitis, and non-alcoholic steatohepatitis.
Conclusion: HbA1c is correlated significantly with hospitalization in type 1 diabetes but not in type 2.
Article Details
Copyright (c) 2022 Alshwikh HE, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Kornum JB, Thomsen RW, Riis A, Lervang HH, Schønheyder HC, et al. Diabetes, Glycemic Control, and Risk of Hospitalization With Pneumonia. Diabetes Care. 2008; 31: 1541-1545. PubMed: https://pubmed.ncbi.nlm.nih.gov/18487479/ DOI: https://doi.org/10.2337/dc08-0138
Mazurek JA, Hailpern SM, Goring T, Nordin C. Prevalence of hemoglobin A1c greater than 6.5% and 7.0% among hospitalized patients without known diagnosis of diabetes at an Urban Inner City Hospital. J Clin Endocrinol Metab. 2010; 95: 1344-1348. PubMed: https://pubmed.ncbi.nlm.nih.gov/20080838/ DOI: https://doi.org/10.1210/jc.2009-1151
Wexler DJ, Nathan DM, Grant RW, Regan S, Van Leuvan AL, et al. Prevalence of elevated hemoglobin A1c among patients admitted to the hospital without a diagnosis of diabetes. J Clin Endocrinol Metab. 2008; 93: 4238-4244. PubMed: https://pubmed.ncbi.nlm.nih.gov/18697862/ DOI: https://doi.org/10.1210/jc.2008-1090
Greci LS, Kailasam M, Malkani S, Katz DL, Hulinsky I, et al. Utility of HbA1c levels for diabetes case finding in hospitalized patients with hyperglycemia. Diabetes care. 2003; 26: 1064-1068. PubMed: https://pubmed.ncbi.nlm.nih.gov/12663574/ DOI: https://doi.org/10.2337/diacare.26.4.1064
Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal T, et al. Intensive glycaemic control for patients with type 2 diabetes: Systematic review with meta-analysis and trial sequential analysis of randomised clinical trials. BMJ. 2011; 343: 1136. PubMed: https://pubmed.ncbi.nlm.nih.gov/22115901/ DOI: https://doi.org/10.1136/bmj.d6898
Patel A, MacMahon S, Chalmers J. Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release and Controlled Evaluation (ADVANCE) Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008; 358: 2560-2572. DOI: https://doi.org/10.1056/NEJMoa0802987
NG A, Sandra JG, Shreekant P. Glycemic Control and Risk of Cardiovascular Disease Hospitalization and All-Cause Mortality. J Am Coll Cardiol. 2013; 62: 121–127. PubMed: https://pubmed.ncbi.nlm.nih.gov/23665365/ DOI: https://doi.org/10.1016/j.jacc.2013.04.031
Shi L, Ye X, Lu M, Wu EQ, Sharma H, et al. Clinical and economic benefits associated with the achievement of both hba1c and LDL cholesterol goals in veterans with type 2 diabetes. Diabetes Care. 2013; 36: 3297-3304. PubMed: https://pubmed.ncbi.nlm.nih.gov/23801723/ DOI: https://doi.org/10.2337/dc13-0149
Critchley JA, Carey IM, Harris T, DeWilde S, Hosking FJ, et al. Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study. Diabetes Care. 2018;41: 2127-2135. PubMed: https://pubmed.ncbi.nlm.nih.gov/30104296/ DOI: https://doi.org/10.2337/dc18-0287
Currie CJ, Peters JR, Tynan A, Evans M, Heine RJ, et al. Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study. Lancet. 2010; 375: 481-489. PubMed: https://pubmed.ncbi.nlm.nih.gov/20110121/ DOI: https://doi.org/10.1016/S0140-6736(09)61969-3
Menzin J, Korn JR, Cohen J, Lobo F, Zhang B, et al. Relationship between glycemic control and diabetes-related hospital costs in patients with type 2 diabetes mellitus. J Manag Care Pharm. 2010; 16: 264-2675. PubMed: https://pubmed.ncbi.nlm.nih.gov/20433217/ DOI: https://doi.org/10.18553/jmcp.2010.16.4.264
Yu D, Simmons D. Relationship between HbA1c and risk of all-cause hospital admissions among people with Type 2 diabetes. Diabet Med. 2013; 30: 1407–1411. PubMed: https://pubmed.ncbi.nlm.nih.gov/23692400/ DOI: https://doi.org/10.1111/dme.12235
Selvin E, Wattanakit K, Steffes MW, Coresh J, Sharrett AR. HbA1c and peripheral arterial disease in diabetes: The atherosclerosis risk in communities study. Diabetes Care. 2006; 29: 877-882. PubMed: https://pubmed.ncbi.nlm.nih.gov/16567831/ DOI: https://doi.org/10.2337/diacare.29.04.06.dc05-2018
Haifa elhadi A, Faiza H. Reasons for admission of individual with diabetes to the Tripoli Medical Center in 2015. Diabetes Metab Syndr Clin Res Rev. 2019; 13: 2571-2578. PubMed: https://pubmed.ncbi.nlm.nih.gov/31405678/ DOI: https://doi.org/10.1016/j.dsx.2019.07.017
Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012; 97: 16-38. PubMed: https://pubmed.ncbi.nlm.nih.gov/22223765/ DOI: https://doi.org/10.1210/jc.2011-2098